← Back to Search

Unknown

AB-2004 for Autism Spectrum Disorder

Phase 2
Waitlist Available
Research Sponsored by Axial Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to week 8 visit
Awards & highlights

Study Summary

This trial will test if AB-2004, a new medication, is safe and effective for treating irritability in teens with autism spectrum disorder.

Eligible Conditions
  • Autism Spectrum Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to week 8 visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to week 8 visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The mean change in the ABC-I score (Irritability) from Baseline to Week 8 for AB-2004
Secondary outcome measures
Number of participants who reported treatment emergent adverse events (TEAEs)
Antibodies

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AB-2004Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Axial Therapeutics, Inc.Lead Sponsor

Media Library

AB-2004 (Unknown) Clinical Trial Eligibility Overview. Trial Name: NCT04895215 — Phase 2
Autism Spectrum Disorder Research Study Groups: AB-2004, Placebo
Autism Spectrum Disorder Clinical Trial 2023: AB-2004 Highlights & Side Effects. Trial Name: NCT04895215 — Phase 2
AB-2004 (Unknown) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04895215 — Phase 2
~42 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top